AHA 2021: Canagliflozin Improves Heart Failure Symptoms, Regardless of Ejection Fraction
The CHIEF-HF trial provides a model for future trials that are conducted entirely virtually
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.